Christopher M. Blanchette

2.4k total citations
84 papers, 1.7k citations indexed

About

Christopher M. Blanchette is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Christopher M. Blanchette has authored 84 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 18 papers in Physiology and 12 papers in Epidemiology. Recurrent topics in Christopher M. Blanchette's work include Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Asthma and respiratory diseases (15 papers) and Respiratory and Cough-Related Research (11 papers). Christopher M. Blanchette is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Asthma and respiratory diseases (15 papers) and Respiratory and Cough-Related Research (11 papers). Christopher M. Blanchette collaborates with scholars based in United States, United Kingdom and Canada. Christopher M. Blanchette's co-authors include Joshua Noone, Anand A. Dalal, Manabu Akazawa, Sandi J. Lane, Douglas W. Mapel, Hans Petersen, Benjamín Gutiérrez, Erik A. Wikstrom, Abbey C. Thomas and Richard H. Stanford and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher M. Blanchette

80 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Blanchette United States 22 738 503 155 143 142 84 1.7k
Suzana Érico Tanni Brazil 23 1.0k 1.4× 530 1.1× 154 1.0× 75 0.5× 173 1.2× 124 1.9k
Irma Godoy Brazil 23 1.3k 1.8× 766 1.5× 124 0.8× 101 0.7× 98 0.7× 105 2.0k
Riccardo Pistelli Italy 26 1.5k 2.0× 769 1.5× 230 1.5× 97 0.7× 103 0.7× 63 2.1k
Elizabeth Robinson New Zealand 25 182 0.2× 455 0.9× 228 1.5× 145 1.0× 188 1.3× 63 2.2k
Gunnar Johansson Sweden 29 1.5k 2.1× 873 1.7× 208 1.3× 139 1.0× 134 0.9× 104 2.3k
Alejandro Casas Colombia 19 1.5k 2.0× 512 1.0× 327 2.1× 275 1.9× 104 0.7× 59 2.2k
Victor A. Kiri United Kingdom 19 822 1.1× 466 0.9× 125 0.8× 106 0.7× 68 0.5× 39 1.4k
Laura Byham‐Gray United States 20 329 0.4× 1.1k 2.1× 97 0.6× 296 2.1× 300 2.1× 126 2.6k
Murray Tilyard New Zealand 21 214 0.3× 458 0.9× 267 1.7× 343 2.4× 229 1.6× 77 2.5k
Stephen Chua United Kingdom 6 1.1k 1.5× 360 0.7× 174 1.1× 147 1.0× 55 0.4× 9 1.4k

Countries citing papers authored by Christopher M. Blanchette

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Blanchette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Blanchette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Blanchette more than expected).

Fields of papers citing papers by Christopher M. Blanchette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Blanchette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Blanchette. The network helps show where Christopher M. Blanchette may publish in the future.

Co-authorship network of co-authors of Christopher M. Blanchette

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Blanchette. A scholar is included among the top collaborators of Christopher M. Blanchette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Blanchette. Christopher M. Blanchette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Nina, et al.. (2023). The Relative Value of Anti-Obesity Medications Compared to Similar Therapies. ClinicoEconomics and Outcomes Research. Volume 15. 51–62. 7 indexed citations
2.
3.
Chen, Chi‐Chang, Catherine B. McGuiness, Girishanthy Krishnarajah, et al.. (2016). Estimated incidence of pertussis in people aged <50 years in the United States. Human Vaccines & Immunotherapeutics. 12(10). 2536–2545. 14 indexed citations
4.
Blanchette, Christopher M., et al.. (2015). Natural Progression of Alpha-1 Antitrypsin Deficiency Among Hospitalized COPD Patients in the US. CHEST Journal. 148(4). 497A–497A. 1 indexed citations
5.
Borrego, Matthew E., et al.. (2014). Assessing Disparities in the Receipt of Inhaled Corticosteroid Prescriptions for Asthma by Hispanic and Non-Hispanic White Patients. Annals of the American Thoracic Society. 12(2). 174–183. 17 indexed citations
6.
Blanchette, Christopher M., et al.. (2014). Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US. Journal of Medical Economics. 18(4). 303–311. 11 indexed citations
7.
Studnicki, James, et al.. (2014). A cross-sectional retrospective analysis of the regionalization of complex surgery. BMC Surgery. 14(1). 55–55. 3 indexed citations
8.
Zyczynski, Teresa, et al.. (2013). Treatment Patterns After Castration Resistant Prostate Cancer (Crpc) Diagnosis: A European Physician Survey. Value in Health. 16(3). A1–A1. 2 indexed citations
9.
Yeaw, Jason, et al.. (2013). Direct medical costs for complications among adults with type 2 diabetes in a us commercial payer setting. Value in Health. 16(3). A190–A190. 1 indexed citations
10.
Blanchette, Christopher M., Anand A. Dalal, & Douglas W. Mapel. (2012). Changes in COPD demographics and costs over 20 years. Journal of Medical Economics. 15(6). 1176–1182. 33 indexed citations
11.
Blanchette, Christopher M., Melissa Roberts, Hans Petersen, Anand A. Dalal, & Douglas W. Mapel. (2011). Economic burden of chronic bronchitis in the United States: a retrospective case-control study. International Journal of COPD. 6. 73–73. 20 indexed citations
12.
Revel‐Vilk, Shoshana, Patcharee Komvilaisak, V. Blanchette, et al.. (2011). The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity. Haemophilia. 17(4). 689–694. 15 indexed citations
13.
Sood, Anil K., Hans Petersen, Christopher M. Blanchette, et al.. (2010). Wood Smoke Exposure and Gene Promoter Methylation Are Associated with Increased Risk for COPD in Smokers. American Journal of Respiratory and Critical Care Medicine. 182(9). 1098–1104. 105 indexed citations
14.
Blanchette, Christopher M., et al.. (2010). Quarterly Assessment of Short-Acting β2-Adrenergic Agonist Use as a Predictor of Subsequent Health Care Use for Asthmatic Patients in the United States. Journal of Asthma. 47(6). 660–666. 18 indexed citations
15.
Raebel, Marsha A., Michael L. Smith, Leslie Wright, et al.. (2010). The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiology and Drug Safety. 19(11). 1204–1208. 7 indexed citations
16.
Blanchette, Christopher M., et al.. (2008). Economic Burden in Direct Costs of Concomitant Chronic Obstructive Pulmonary Disease and Asthma in a Medicare Advantage Population. Journal of Managed Care Pharmacy. 14(2). 176–185. 62 indexed citations
17.
Blanchette, Christopher M., Jane M. Simoni, Ilene H. Zuckerman, & Bruce Stuart. (2008). A Secondary Analysis of a Duration Response Association Between Selective Serotonin Reuptake Inhibitor Use and the Risk of Acute Myocardial Infarction in the Aging Population. Annals of Epidemiology. 18(4). 316–321. 23 indexed citations
18.
Shaya, Fadia T., Manabu Akazawa, Christopher M. Blanchette, et al.. (2008). Burden of Concomitant Asthma and COPD in a Medicaid Population*. CHEST Journal. 134(1). 14–19. 111 indexed citations
19.
Blanchette, Christopher M., Manabu Akazawa, Anand A. Dalal, & Jane M. Simoni. (2008). Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 µg/salmeterol 50 µg compared with ipratropium for chronic obstructive pulmonary disease in older adults. ˜The œAmerican journal of geriatric pharmacotherapy. 6(3). 138–146. 10 indexed citations
20.
Blanchette, Christopher M., et al.. (2006). Cost and utilization of blood transfusion associated with spinal surgeries in the United States. European Spine Journal. 16(3). 353–363. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzana Érico Tanni Breakdown of academic impact, for papers by Irma Godoy Breakdown of academic impact, for papers by Riccardo Pistelli Breakdown of academic impact, for papers by Elizabeth Robinson Breakdown of academic impact, for papers by Gunnar Johansson Breakdown of academic impact, for papers by Alejandro Casas Breakdown of academic impact, for papers by Victor A. Kiri Breakdown of academic impact, for papers by Laura Byham‐Gray Breakdown of academic impact, for papers by Murray Tilyard Breakdown of academic impact, for papers by Stephen Chua
Rankless by CCL
2026